Indian drug firms to face challenges in US market: ICRA

Indian drug firms to face challenges in US market: ICRA

Indian drug firms have registered strong growth over last decade driven mainly by the US market on account of large brands going off patent and sizeable organic and inorganic expansion.

Sun Pharma gains nearly 3% as company buys 14 brands from Novartis

Shares of Sun Pharma rose by nearly 3 percent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for USD 293 million (over Rs 1,940 crore).

Plethico adopts contract manufacturing model to sustain biz

Plethico Pharmaceuticals has adopted contract manufacturing model in order to sustain its business operations.

Expert analysis on Pharmaceuticals sector

Share Bazar, Mandi Live, Aap Ka Bazar, First Trade, Big Debate etc.

Govt to formulate policy to promote bulk drug manufacturing

Government is examining the recommendations of a committee set up to study the issues related to critical active pharmaceutical ingredients (APIs) so as to formulate a policy for promoting their manufacturing in the country.

Nifty rises after hitting 1-1/2 month low; defensives lead

The Nifty rose after hitting nearly 1-1/2 month low on Tuesday as investors churned positions in defensive stocks such as Lupin Ltd from pharmaceutical sector on worries the record setting rally has run ahead of fundamentals.

Old-economy sectors are now tech, too: US study

Forget about old economy and new economy. Everything is now part of the tech economy, a prominent US research panel said Monday.

No non-compete clause in case of FDI in pharma deals

India allows 100 percent FDI in pharma sector.

A Quality Career

India`s pharmaceutical sector is expected to touch US$ 74 billion in sales by 2020. This means fresher will have promising career opportunities in the quality function, says Dr. Rajkumar

Pharma cos likely to post 15% profit growth in Q3 FY'14

Pharmaceutical companies are expected to post core profit growth of over 15 percent, year-on-year, for the quarter ended December 2013.

FDI in pharma sector jumps 86.5% during April-Oct period

FDI in the pharmaceutical sector jumped by 86.5 percent to USD 1.08 billion during April- October period of the current fiscal amid concerns over continuous mergers and acquisitions of domestic drug makers by multinationals.

No clear gainers if Pharma FDI is capped

Moreover, Indian pharma industry is pretty fragmented, so it is difficult for few players to control the whole pharma market.

FIPB to take up 32 foreign investment proposals today

Six pharmaceutical sector proposals, in addition to 26 others, will come up for approval before the Foreign Investment Promotion Board (FIPB) on Tuesday.

FIPB clears 6 pharma proposals worth Rs 855 cr

The Foreign Investment Promotion Board (FIPB) Monday cleared six proposals envisaging investments of Rs 855 crore in the pharmaceutical sector, including one by Fresenius Kabi.

Pharma exports rise 10% to $14.6 bn in FY’13

Pharma exports grew by 10.55 percent year-on-year to USD 14.6 billion during the financial year 2012-13, a top official of industry body Pharmexcil said.

Indian pharma industry seeks policy reforms in Indonesia

India hopes the Indonesian government will undertake policy reforms that will enable Indian companies to invest in the South-East Asian nation's pharmaceutical sector.

New drug policy will hurt investment in pharma sector: Industry

Prices of various leading drug brands will come down by up to 80 percent thanks to the newly-approved National Pharmaceutical Pricing Policy but at the same time it will hurt investment sentiments in the country's pharmaceutical sector, according to industry bodies.